Capital Analysts LLC’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-9
| Closed | -$2K | – | 1562 |
|
|
2025
Q4 | $2K | Hold |
9
| – | – | ﹤0.01% | 1410 |
|
|
2025
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 1408 |
|
|
2025
Q2 | $1K | Sell |
9
-11
| -55% | -$1.35K | ﹤0.01% | 1352 |
|
|
2025
Q1 | $3K | Hold |
20
| – | – | ﹤0.01% | 1286 |
|
|
2024
Q4 | $3K | Buy |
20
+9
| +82% | +$1.26K | ﹤0.01% | 1199 |
|
|
2024
Q3 | $2K | Buy |
+11
| New | +$1.59K | ﹤0.01% | 1218 |
|
|
2024
Q1 | – | Sell |
-134
| Closed | -$18K | – | 1128 |
|
|
2023
Q4 | $18K | Sell |
134
-46
| -26% | -$5.61K | ﹤0.01% | 823 |
|
|
2023
Q3 | $22K | Buy |
180
+46
| +34% | +$5.85K | ﹤0.01% | 752 |
|
|
2023
Q2 | $17K | Hold |
134
| – | – | ﹤0.01% | 747 |
|
|
2023
Q1 | $17K | Hold |
134
| – | – | ﹤0.01% | 751 |
|
|
2022
Q4 | $18K | Hold |
134
| – | – | ﹤0.01% | 780 |
|
|
2022
Q3 | $16K | Hold |
134
| – | – | ﹤0.01% | 740 |
|
|
2022
Q2 | $16K | Sell |
134
-18,432
| -99% | -$2.19M | ﹤0.01% | 729 |
|
|
2022
Q1 | $2.42M | Sell |
18,566
-2,327
| -11% | -$303K | 0.15% | 130 |
|
|
2021
Q4 | $3.19M | Sell |
20,893
-9,494
| -31% | -$1.47M | 0.19% | 107 |
|
|
2021
Q3 | $4.91M | Sell |
30,387
-1,878
| -6% | -$316K | 0.32% | 63 |
|
|
2021
Q2 | $5.28M | Sell |
32,265
-12,395
| -28% | -$1.91M | 0.35% | 60 |
|
|
2021
Q1 | $6.72M | Buy |
44,660
+44,651
| +496,122% | +$7.09M | 0.46% | 38 |
|
|
2020
Q4 | $1K | Sell |
9
-960
| -99% | -$137K | ﹤0.01% | 721 |
|
|
2020
Q3 | $131K | Sell |
969
-1,515
| -61% | -$206K | 0.01% | 283 |
|
|
2020
Q2 | $340K | Buy |
2,484
+1,485
| +149% | +$189K | 0.04% | 197 |
|
|
2020
Q1 | $108K | Sell |
999
-17
| -2% | -$1.96K | 0.01% | 250 |
|
|
2019
Q4 | $122K | Buy |
1,016
+29
| +3% | +$3.23K | 0.01% | 276 |
|
|
2019
Q3 | $98K | Buy |
987
+71
| +8% | +$7.43K | 0.01% | 283 |
|
|
2019
Q2 | $100K | Hold |
916
| – | – | 0.01% | 273 |
|
|
2019
Q1 | $102K | Hold |
916
| – | – | 0.01% | 262 |
|
|
2018
Q4 | $88K | Hold |
916
| – | – | 0.01% | 253 |
|
|
2018
Q3 | $112K | Buy |
916
+16
| +2% | +$1.88K | 0.01% | 238 |
|
|
2018
Q2 | $99K | Sell |
900
-5
| -0.6% | -$535 | 0.01% | 249 |
|
|
2018
Q1 | $97K | Sell |
905
-2,020
| -69% | -$224K | 0.01% | 247 |
|
|
2017
Q4 | $312K | Hold |
2,925
| – | – | 0.04% | 174 |
|
|
2017
Q3 | $325K | Buy |
2,925
+375
| +15% | +$40.1K | 0.04% | 168 |
|
|
2017
Q2 | $264K | Hold |
2,550
| – | – | 0.04% | 176 |
|
|
2017
Q1 | $249K | Buy |
+2,550
| New | +$244K | 0.04% | 164 |
|
|
2016
Q4 | – | Sell |
-1,905
| Closed | -$184K | – | 367 |
|
|
2016
Q3 | $184K | Buy |
+1,905
| New | +$181K | 0.03% | 174 |
|
|
2016
Q2 | – | Sell |
-1,050
| Closed | -$91.3K | – | 356 |
|
|
2016
Q1 | $91.3K | Sell |
1,050
-2,475
| -70% | -$221K | 0.02% | 219 |
|
|
2015
Q4 | $398K | Buy |
+3,525
| New | +$383K | 0.08% | 152 |
|
Other funds holding IBB
CB
Capital Analysts LLC's IBB Position: Q1 2026 in Review
Capital Analysts LLC sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 9 shares — an estimated $2K sold.
Capital Analysts LLC first reported a position in IBB in Q4 2015 and held it in 37 quarters. The position peaked at $6.72M in Q1 2021. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Capital Analysts LLC reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
- Capital Analysts LLC sold 9 iShares Biotechnology ETF shares in Q1 2026, an estimated $2K.
- Capital Analysts LLC first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 37 quarters.
- Capital Analysts LLC's iShares Biotechnology ETF position peaked at $6.72M in Q1 2021.
- 921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.